Steriline, an European manufacturer of highly specialized robotic filling machines and complete aseptic filling/finishing lines, will attend Interphex, the leading global pharmaceutical and biotechnology event that fosters collaborations and provides a comprehensive view of advancements in the pharmaceutical industry. The company will welcome visitors on 1-3 April 2025 at stand 2537 in the Javits Center, NYC, displaying a Robotic Vial Filling Machine utilizing Planar Motor technology, a magnetically levitated transport system.
The innovative solution consists of a unique platform that levitates movers above a stainless surface providing 6 degrees of precise motion and zero friction. This allows for the transport of containers (vials, syringes, cartridges, etc.) from station to station in the filling and closing operation, without any mechanical components or particle generation. The combination of this technology, and the use of robotics for loading and unloading, results in a highly flexible and clean platform. Planar motor technology has been deployed by Steriline on recent customer filling systems with great success.
“Steriline continues to lead the industry in Robotic implementations in aseptic environments with over 150 robotic systems deployed over the past decade, showing that we are early adopters of innovative technologies and capable of bringing them to commercialization,” says James Rorke, VP of Steriline North American Operations. “The development of Planar Motor technologies in aseptic environments further pushes the envelope towards greater flexibility and increased contamination control.”
“The revision of EU GMP Annex 1 is boosting the adoption, in the pharmaceutical industry, of technologies able to improve the quality of products and the safety of operators,” affirms Federico Fumagalli, chief commercial officer at Steriline. “Steriline’s R&D department always looks to the future with the aim of identifying technological opportunities, such as the Planar Motor solution, to be implemented in our equipment. It is thanks to this far-sighted vision that progress is facilitated, with Steriline aiming to become an even stronger reference supplier for the pharmaceutical industry.”
ABOUT STERILINE
Steriline is a well-established European manufacturer, highly specialized in the production of complete lines for the aseptic processing of injectable and ophthalmic products, supplying pharmaceutical companies worldwide.
Steriline was founded in 1989 in the Lake Como area (Italy), where its headquarters and manufacturing facilities are still based. With operations in over 50 countries around the world, Steriline has a network of approximately 400 people, including direct employees and external partners, in addition to 40 local sales representatives. Exports represent more than 90% of Steriline’s turnover, with over 2,000 machines installed throughout Asia, Europe and the U.S.A.
Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanical and robotic applications for aseptic processing. These applications are consistent with vials, ampoules, cartridges and syringes and can handle toxic or non-toxic products in both liquid and powder form. Steriline’s complete lines include equipment ranging from washing machines, depyrogenation tunnels, filling and capping machines, to external decontamination machines and barrier systems such as LAF, oRABS, cRABS and isolators.
